The Protection of Thyroid Function in IMRT for Nasopharyngeal Carcinoma
NCT06268600 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 320
Last updated 2024-04-11
Summary
This study aimed to reduce radiation-induced thyroid injury without compromising control of the cervical region by optimizing the delineation of the cervical lymph node drainage area.
Conditions
- Nasopharyngeal Carcinoma
- Nasopharyngeal Cancer
- Hypothyroidism
Interventions
- RADIATION
-
Modified neck target volume delineation
Modified neck target volume delineation method was used to define the inner boundary of regions III and IVa as the outer edge of the common carotid artery.
Sponsors & Collaborators
-
Jiangxi Provincial Cancer Hospital
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-01
- Primary Completion
- 2024-11-30
- Completion
- 2025-11-30
Countries
- China
Study Locations
More Related Trials
-
Differentiated Thyroid Cancer Patients Treated With Different Doses of Radioactive Iodine.
NCT06134830 ·Status: NOT_YET_RECRUITING
-
The Initial Management in Patients With Differentiated Thyroid Cancer in the Real World in China
NCT04857086 ·Status: UNKNOWN
-
Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma
NCT06087068 ·Status: RECRUITING ·Phase: PHASE2
-
Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment
NCT06405217 ·Status: RECRUITING ·Phase: NA
-
Image-guided Thermal Ablation vs. Lobectomy for Solitary Papillary Thyroid Microcarcinoma
NCT06325787 ·Status: COMPLETED ·Phase: NA
-
Clinical Efficacy of 125I Seed Implantation in the Treatment of Refractory Differentiated Thyroid Cancer
NCT06362772 ·Status: COMPLETED
-
Thyroid Cancer in United Arab Emirates
NCT04763122 ·Status: COMPLETED
-
Assessment of Quality of Life After Adjunct Radioiodine Therapy in Patients With Differentiated Thyroid Cancer
NCT02706743 ·Status: UNKNOWN
-
Clinical Evaluation of Genetron TERT/BRAF PCR Kit in Thyroid Cancer Patients
NCT05395429 ·Status: UNKNOWN
-
I-124 PET/CT Based Remnant Radioiodine Ablation Decision Concept in Differentiated Thyroid Cancer
NCT01704586 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Incidence and Risk Factors of Radiotherapy Induced Hypothyroidism in Head and Neck Cancer With Long Term Follow up
NCT03699098 ·Status: COMPLETED ·Phase: NA
-
Cognitive Functions During Thyrotropin Suppressive Therapy in Patients With Differentiated Thyroid Carcinoma
NCT02665325 ·Status: UNKNOWN
-
Impact of Thyroid Treatment on Ovarian Function and Pregnancy Outcomes in Women with Differentiated Thyroid Cancer
NCT06845098 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Review of Multimodality Management of Anaplastic Thyroid Cancer
NCT00280852 ·Status: COMPLETED
-
a. Reducing Radioiodine Treatment in Papillary Thyroid Cancer. RAILESS
NCT06271044 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Taiwanese Anaplastic Thyroid Cancer Registry
NCT07138261 ·Status: NOT_YET_RECRUITING
-
Effect of Thyrotropin Level on Iodine Uptake in Metastatic Differentiated Thyroid Cancer
NCT04880798 ·Status: UNKNOWN ·Phase: NA
-
To Study the Impact of Radiation Treatment After Surgery in Patient With Locally Advanced Thyroid Cancer.
NCT03669432 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Correlation Between TCM Syndrome Factors and TSH Changes of Thyroid Hormone Withdrawal Before Iodine Therapy in Postoperative Patients With Thyroid Cancer
NCT04916262 ·Status: UNKNOWN
-
Use of an In Vivo Optical Probe to Discriminate Benign From Malignant Thyroid Nodules
NCT01401855 ·Status: COMPLETED
-
I-124 PET/CT Imaging and Dosimetry for RAI-Naïve or Refractory Thyroid Cancer
NCT06443866 ·Status: RECRUITING
-
Initial Management in Patients With Differentiated Thyroid Cancer in the Real World in China
NCT02638077 ·Status: UNKNOWN
-
HRQOL in Locally Advanced Thyroid Carcinoma
NCT05824312 ·Status: RECRUITING
-
Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer
NCT06961084 ·Status: RECRUITING ·Phase: PHASE2
-
Combined Levothyroxine/Liothyronine Supplementation in Hypothyroid Patients With Brain Tumors
NCT00488644 ·Status: TERMINATED ·Phase: NA